ScinoPharm Taiwan Ltd (1789) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.019x

Based on the latest financial reports, ScinoPharm Taiwan Ltd (1789) has a cash flow conversion efficiency ratio of 0.019x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$199.47 Million ≈ $6.28 Million USD) by net assets (NT$10.31 Billion ≈ $324.91 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 1789 defensive interval ratio to measure how many days the company can operate on defensive assets alone.

ScinoPharm Taiwan Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how ScinoPharm Taiwan Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ScinoPharm Taiwan Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ScinoPharm Taiwan Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jinlong Machinery Electronic SHE:300032	0.078x
Salim Ivomas Pratama Tbk JK:SIMP	0.048x
Ventec International Group Co Ltd TW:6672	0.024x
Posiflex Technology Inc TW:8114	-0.061x
Seoul Semiconductor Co. Ltd KQ:046890	0.067x
Symphony Limited NSE:SYMPHONY	0.133x
One Liberty Properties Inc NYSE:OLP	0.015x
Marcopolo S.A SA:POMO3	0.205x

Annual Cash Flow Conversion Efficiency for ScinoPharm Taiwan Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of ScinoPharm Taiwan Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see ScinoPharm Taiwan Ltd stock valuation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$10.52 Billion ≈ $331.59 Million	NT$597.11 Million ≈ $18.81 Million	0.057x	-20.47%
2024-12-31	NT$10.53 Billion ≈ $331.62 Million	NT$750.91 Million ≈ $23.66 Million	0.071x	+219.91%
2023-12-31	NT$10.36 Billion ≈ $326.54 Million	NT$231.13 Million ≈ $7.28 Million	0.022x	-69.88%
2022-12-31	NT$10.45 Billion ≈ $329.23 Million	NT$773.79 Million ≈ $24.38 Million	0.074x	+52.66%
2021-12-31	NT$10.51 Billion ≈ $331.16 Million	NT$509.82 Million ≈ $16.06 Million	0.049x	-46.03%
2020-12-31	NT$10.53 Billion ≈ $331.73 Million	NT$946.31 Million ≈ $29.81 Million	0.090x	+16.88%
2019-12-31	NT$10.26 Billion ≈ $323.24 Million	NT$788.95 Million ≈ $24.86 Million	0.077x	-34.20%
2018-12-31	NT$10.54 Billion ≈ $332.04 Million	NT$1.23 Billion ≈ $38.80 Million	0.117x	+25.28%
2017-12-31	NT$10.42 Billion ≈ $328.20 Million	NT$971.71 Million ≈ $30.61 Million	0.093x	-42.70%
2016-12-31	NT$10.23 Billion ≈ $322.23 Million	NT$1.67 Billion ≈ $52.46 Million	0.163x	+53.63%
2015-12-31	NT$9.86 Billion ≈ $310.55 Million	NT$1.04 Billion ≈ $32.91 Million	0.106x	+11.90%
2014-12-31	NT$9.38 Billion ≈ $295.53 Million	NT$888.29 Million ≈ $27.99 Million	0.095x	-2.80%
2013-12-31	NT$9.64 Billion ≈ $303.82 Million	NT$939.47 Million ≈ $29.60 Million	0.097x	-9.97%
2012-12-31	NT$9.07 Billion ≈ $285.78 Million	NT$981.55 Million ≈ $30.92 Million	0.108x	-28.44%
2011-12-31	NT$8.56 Billion ≈ $269.67 Million	NT$1.29 Billion ≈ $40.78 Million	0.151x	-35.46%
2010-12-31	NT$6.68 Billion ≈ $210.37 Million	NT$1.56 Billion ≈ $49.29 Million	0.234x	-19.27%
2009-12-31	NT$4.47 Billion ≈ $140.89 Million	NT$1.30 Billion ≈ $40.89 Million	0.290x	-29.06%
2008-12-31	NT$3.44 Billion ≈ $108.39 Million	NT$1.41 Billion ≈ $44.34 Million	0.409x	+105.43%
2007-12-31	NT$2.53 Billion ≈ $79.82 Million	NT$504.50 Million ≈ $15.89 Million	0.199x	--

About ScinoPharm Taiwan Ltd

TW:1789 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$499.50 Million

NT$15.85 Billion TWD

Market Cap Rank

#12444 Global

#470 in Taiwan

Share Price

NT$20.05

Change (1 day)

-0.25%

52-Week Range

NT$16.35 - NT$28.25

All Time High

NT$55.57